e-learning
resources
Stockholm 2007
Monday 17.09.2007
Cystic fibrosis lung disease: from diagnosis to end-stage
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early detection of lung disease in cystic fibrosis
B. Linnane, G. Hall, S. Brennan, S. Stick, P. Sly, C. Robertson, P. Robinson, S. Ranganathan (Melbourne, Perth, Australia)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Session:
Cystic fibrosis lung disease: from diagnosis to end-stage
Session type:
Oral Presentation
Number:
2659
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Linnane, G. Hall, S. Brennan, S. Stick, P. Sly, C. Robertson, P. Robinson, S. Ranganathan (Melbourne, Perth, Australia). Early detection of lung disease in cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 2659
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis
Source: Eur Respir J 2001; 17: 281-286
Year: 2001
Value of bronchoalveloar lavage (BAL) in management of lung infections in adult cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010
Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001
CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Investigations of broncho-alveolar lavage in children with asthma, bronchiectasis and cystic fibrosis
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
Year: 2003
Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL
Source: Eur Respir J 2003; 22: 497-502
Year: 2003
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Correlation between imaging fibrosis severity and bronchoalveolar lavage pattern in interstitial lung disease
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis
Source: Eur Respir J 2001; 17: 716-722
Year: 2001
Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema
Source: Eur Respir J 2005; 25: 275-281
Year: 2005
Frequent detection of rhinovirus in bronchoalveolar lavage samples from children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Association between lobe specific bronchoalveolar lavage fluid metabolites and structural lung disease in young children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept